Skip to main content

Market Overview

Tekmira Up 6% On Leerink Initiation


Shares of Tekmira Pharmaceuticals (NASDAQ: TKMR) are up six percent in Monday’s pre-market trading following commentary by Leerink partners.

Leerink initiated coverage at Outperform and assigned a $25 price target.

Monday’s rally follows a 50 percent peak to trough selloff last week and 10 percent climb Friday.

Shares of Tekmira were last trading at $19.25, up 6.47 percent.

Latest Ratings for TKMR

Jun 2015Maxim GroupDowngradesBuyHold
Jun 2015Maxim GroupDowngradesHold
Nov 2014Stifel NicolausMaintainsBuy

View More Analyst Ratings for TKMR
View the Latest Analyst Ratings


Related Articles (TKMR)

View Comments and Join the Discussion!

Posted-In: LeerinkPrice Target Initiation Analyst Ratings Movers

Latest Ratings

LBCredit SuisseMaintains36.0
TRGPCredit SuisseMaintains40.0
SNOWCredit SuisseMaintains275.0
DARCredit SuisseMaintains95.0
CLRMKM PartnersDowngrades26.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at